Qilian International - QLI Net earnings per share growth forecast for next year

Corporate emblem and logo of Qilian International Holding (QLI)

Delisting risks and US-China trade barriers are weighing on Qilian International (QLI) shares. Shifts in analyst EPS growth estimates reflect the current trend, where the parameter value equals 0.00. Revenues are based on the sale of herbal extracts and heparin through pharmacies. Supply stability is ensured by regional hubs that optimize the procurement of botanical raw materials for the plants.

QLI: Qilian International Holding Group Limited Consensus forecast of earnings per share growth for next year 07/04/2022 - 08/17/2024

QLI (Qilian International Holding): analytical breakdowns and indicator data

Basic company analysis:QLI, Qilian International Holding
Finished products of qlsyy.net

This growth benchmark for next year's net income per share reflects the analysts' consensus forecast regarding EPS growth rates, enabling the timely detection of asset overvaluation following earnings reports. For Qilian International (QLI), this trend confirms the effectiveness of production line modernization and expansion into the veterinary sector, transforming estimated profit expectations into an objective indicator of the business's fundamental stability.

Competing companies

Net earnings per share growth forecast for next year Haleon plc|Expected net earnings per share growth next year kenvue.com KVUE|Net earnings per share growth forecast for next year Verona Pharma (VRNA)|MENS (Jyong Biotech Limited) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ligand Pharma LGND|Earnings growth forecast for next year Amneal Corp AMRX|Perrigo Company PLC - Earnings growth forecast for next year|ALVO: Net earnings per share growth forecast for next year|liquidia.com (LQDA) - Net earnings per share growth forecast for next year|GLPG (Galapagos) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year ANIP|Projected earnings per share growth rate for next year MNKD (Afrezza)|Earnings growth forecast for next year AMPH|PCRX (Pacira BioSciences) - Expected earnings per share trend next year|Earnings growth forecast for next year SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Net earnings per share growth forecast for next year|Aquestive Corp - Earnings growth forecast for next year|scpharmaceuticals.com (SCPH) - Expected earnings per share growth for next year|TECX: Earnings growth forecast for next year|Tonix Pharmaceuticals - Expected earnings per share trend next year|Expected earnings per share growth for next year SXTC|EPRX: Expected earnings per share trend next year|Expected earnings per share growth for next year BHST (BioHarvest Sciences Inc.)|Consensus forecast of earnings per share growth for next year Invizyne|Net earnings per share growth forecast for next year Oramed Pharmaceuticals ORMP|Expected earnings per share trend next year ENTX|HYFT - Net earnings per share growth forecast for next year|Expected earnings per share trend next year ABVC (ABVC BioPharma Inc.)|CPIX: Earnings growth forecast for next year|Quantum BioPharma Limited - Expected earnings per share trend next year|FGEN (FibroGen Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year Telomir Pharmaceuticals|Earnings growth forecast for next year RANI|SNYR (Synergy CHC Corp.) - Expected earnings per share trend next year|Earnings growth forecast for next year RLYB (Rallybio Corp)|LEXX: Projected earnings per share growth rate for next year|PULM - Net earnings per share growth forecast for next year|PTHL: Net earnings per share growth forecast for next year|APM (aptorumgroup.com) - Expected earnings per share growth for next year|Lyra Therapeutics - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year YCBD|PRFX: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year altamiratherapeutics.com CYTO|Earnings growth forecast for next year Lipella Pharmaceuticals Inc LIPO|OPTN - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Pieris Pharma PIRS|Procaps Group SA (PROC) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PTPI (Petros Pharmaceuticals, Inc.)|Expected earnings per share growth for next year SLRN|TFF Pharmaceuticals, Inc. - Net earnings per share change forecast for next year